Home

The publication highlights the first-ever independent, multicentre study investigating the applicability of the Surfacer system, a novel approach to achieving right-sided, upper body central venous access in patients with obstructions or other conditions that preclude central venous access by conventional methods. The study was directed by lead investigator and the publication’s senior author, Gürkan Sengölge, associate professor of Medicine, Nephrology and Intensive Care Medicine at the Medical University of Vienna (Vienna, Austria). Sengölge is a long-time supporter of the Surfacer system, approaching 50 cases successfully completed to-date.

The present study enrolled 32 patients, the majority (83%) of which had either Type 3 or 4 complex obstructions (3 or more occluded vessels). Of those enrolled, 97% met both the primary and secondary efficacy endpoints of achieving central venous access through the use of the Surfacer system and catheter patency at three months. No procedure-related complications were observed and no catheter-related infections occurred within the first week after catheter placement.

“Thoracic central venous occlusion is a significant issue, which can impact long-term morbidity, particularly in haemodialysis patients who depend on central venous catheters for dialysis therapy,” explained Roman Reindl-Schwaighofer, from the Division of Nephrology at Medical University Vienna, and first author on the study. “This study demonstrates that the Surfacer system is a reliable and safe means of repeatedly establishing vascular access, currently a challenge with alternative surgical options or sharp recanalisation techniques.”

“The erosion of subclavian and left-sided vascular access routes are of great concern to this patient population due to their higher rates of central stenosis and catheter dysfunction,” stated Vladimir Matoussevitch, vascular surgeon and head of the Vascular Access Unit at the University Hospital of Cologne(Cologne, Germany).

James Gilbert, transplant and access surgeon from University Oxford Hospitals NHS Trust (Oxford, UK), further emphasised the clinical importance of the system, pointing out: “The Surfacer system supports the recommended ‘always right, never subclavian’ approach to preserving vascular real estate in a challenging patient population.”

“This study adds to the growing body of evidence highlighting the need for standardised treatment of central venous occlusions and demonstrating the positive clinical impact of the Surfacer System,” stated Gabriele Niederauer, CEO and president of Bluegrass Vascular. “We look forward to broadening our clinical partnerships in Europe and the USA to best support this effort.”

Source VascularNews

Duc Tin CLinic

Chia sẽ qua facebook bài: Positive Surfacer Inside-Out multicentre study results published

Chia sẽ qua google bài: Positive Surfacer Inside-Out multicentre study results published

Chia sẽ qua twitter bài: Positive Surfacer Inside-Out multicentre study results published

Chia sẽ qua MySpace bài: Positive Surfacer Inside-Out multicentre study results published

Chia sẽ qua LinkedIn bài: Positive Surfacer Inside-Out multicentre study results published

Chia sẽ qua stumbleupon bài: Positive Surfacer Inside-Out multicentre study results published

Chia sẽ qua icio bài: Positive Surfacer Inside-Out multicentre study results published

Chia sẽ qua digg bài: Positive Surfacer Inside-Out multicentre study results published

Chia sẽ qua yahoo bài: Positive Surfacer Inside-Out multicentre study results published

Tin tức liên quan

Vesteck completes first-in-human use of several Suture-Tight devices

Age is just a number: Individual patient data meta-analysis probes safety of CEA in the elderly

Artificial intelligence can predict risk of complications after endovascular aneurysm repair

Bluegrass Vascular announces Journal of Vascular Surgery paper reporting use of Surfacer system

Vascular access creation: EndoAVF keeps future options open, but is not a replacement for surgical fistulas

SUPPORT CONSULTANT

Make an Appointment

I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

I sincerely thank you !. Tel: 0938303275

Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.